Cargando…
Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
BACKGROUND: Febrile neutropenia (FN) and myelosupression remain a challenging oncologic medical emergency and dose limiting toxicity associated with chemotherapy for cancers. Various factors are known to affect the outcomes for patients diagnosed with FN. Electrolyte abnormalities have commonly been...
Autores principales: | Shaikh, Asim Jamal, Bawany, Samira Ahmed, Masood, Nehal, Khan, Ausaf Ahmed, Abbasi, Ahmed Nadeem, Niamutullah, Syed Najeeb, Zaidi, Adnan, Adil, Salman, Kumar, Shiyam |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039222/ https://www.ncbi.nlm.nih.gov/pubmed/21326626 |
Ejemplares similares
-
Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature
por: Masood, Nehal, et al.
Publicado: (2008) -
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
por: Ray-Coquard, I, et al.
Publicado: (2003) -
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
por: Perron, Thomas, et al.
Publicado: (2014) -
Gemella Haemolysans Infective Endocarditis in a Patient With Febrile Neutropenia
por: Eslinger, Logan J, et al.
Publicado: (2022) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)